Manufacturing, Cell-Line Selection

Cytiva Acquires CEVEC, Boosts Cell Line Development Capabilities

October 10, 2022

Cytiva’s acquisition of CEVEC Pharmaceuticals strengthens the company’s cell line development and biomanufacturing capabilities.

Thermo Fisher Scientific Launches Large-Scale Cell Culture Harvesting Solution

October 07, 2022

Thermo Fisher’s new centrifuge technology is designed to enable efficient, sustainable cell culture harvesting.

Catalent Biologics Launches New Cell Line Expression Technology

July 22, 2021

Catalent Biologics has launched its new cell line expression technology, GPEx Lightning, which aims to shorten drug substance development timelines by up to three months.

New Biotherapies Push Technological Innovation Forward

June 03, 2021

The emergence of new biotherapeutics is both the driver and result of innovative drug development technologies.

Berkeley Lights Launches Assay Series for Early Cell-Line Development Yield and Product Quality

April 06, 2021

The company has introduced Opto Assure, a series of assays that provide yield and product quality data at an earlier stage in cell-line development.

Samsung Biologics Incorporates Solentim’s Cell Line Development Technology into New R&D Center

November 05, 2020

Samsung Biologics has adopted Solentim’s cell seeding and cell metric platforms at its new R&D center in San Francisco, CA.

New EpiMOGRIFY Technology Platform Offers Development Support for Allogeneic Cell Therapies

November 04, 2020

Mogrify’s new technology platform, EpiMOGRIFY, can predict cellular switches important for determining cell identity, cell maintenance, directed differentiation, and cell conversion.

Samsung Biologics Expands Manufacturing Facilities and Launches Cell Line Technology

August 13, 2020

The company has made several moves in recent weeks to expand manufacturing capacity and cell line services.

Dyadic International Selected for COVID-19 Vaccine Candidate Development

June 11, 2020

The candidates will be used by the Vaccine Research Center, part of the National Institute of Allergy and Infectious Diseases at the National Institutes of Health.

Catalent Partners with Spicona for COVID-19 Vaccine Development

June 10, 2020

Catalent will use its GPEx cell line development technology to create a cell line expressing the recombinant VLP at its Madison, WI facility.